HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weijie Peng Selected Research

Weijie Peng Research Topics

Disease

1Carcinogenesis
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Neoplasms (Cancer)
01/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Body Weight (Weight, Body)
01/2021
1Colitis
01/2021
1Hemorrhage
01/2021
1Inflammation (Inflammations)
01/2021
1Osteoporosis
11/2017
1Postmenopausal Osteoporosis
06/2015
1Bone Resorption
07/2014
1Ischemia
10/2011
1Reperfusion Injury
10/2011

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
2Estrogen ReceptorsIBA
11/2017 - 06/2015
1Leucine (L-Leucine)FDA Link
01/2022
1UbiquitinIBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1Protein Phosphatase 1IBA
01/2022
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Peroxidase (Myeloperoxidase)IBA
01/2021
1CytokinesIBA
01/2021
1Dextran SulfateIBA
01/2021
1Lipopolysaccharide ReceptorsIBA
01/2021
1Amine Oxidase (Copper-Containing)IBA
01/2021
1Estrogens (Estrogen)FDA Link
11/2017
1GenisteinIBA
07/2014
1daidzeinIBA
07/2014
1Phytoestrogens (Phytoestrogen)IBA
07/2014
122-O-angeloylcamelliagenin C- 3- O- (glucopyranosyl- 1- 2)(glucopyranosyl- 1- 2- O- arabinopyranosyl- 1- 3- )glucopyranosiduronic acidIBA
10/2011
1Chloride-Bicarbonate AntiportersIBA
10/2011

Therapy/Procedure

1Estrogen Replacement Therapy
06/2015